Arizona Politics

Poll Suggests Majority of Americans in Favor of Trump's Pharmaceutical Executive Order

A recent poll released by the Pharmaceutical Reform Alliance (PRA) found that a majority of Americans approve of President Donald Trump's executive order aimed at lowering drug prices for pharmaceutical companies.

President Trump issued the order in mid-May, arguing that other countries have drastically lower drug prices because their governments are the single buyers and sellers of products. As a result, Trump's executive order aims to force pharmaceuticals to raise their prices in other countries by capping the permitted price of drugs sold in the US at the cost of the country with the lowest price for drugs.

Ideally, drug prices would decline 30 to 80% as a result of this plan.

Despite some criticism from Republicans, such as former Speaker of the House Newt Gingrich, the PRA found that most Americans expressed support for the order.

After all, 86% of respondents said they know someone who is on prescription medication, and 85% said medications are getting more expensive, which 84% blame the pharmaceutical companies for.

78% of respondents expressed favorability with Trump's May executive order, including 61% of Democrats and 59% of Kamala Harris voters.

Other aspects of the poll found that 89% of Americans want pharmaceutical advertisements to disclose the prices of products or, at the very least, restrict the pharmaceutical companies' ability to advertise altogether.

90% of respondents did not want Congressional candidates to take money from "Big Pharma," while 86% said they would favor a candidate in line with reducing the price of pharmaceuticals.

"Americans are speaking loudly and clearly, so it's important for Congress to listen: the time to join President Trump in lowering prescription drug costs is NOW," said PRA spokesman J.D. Hayworth, adding, " From coast to coast, the American people are suffering from high prescription costs, and they rightly blame Big Pharma. Simply stated, it's time for Big Pharma to put America first…not last."

Grayson Bakich

Grayson Bakich is a Florida and Arizona legislative correspondent for The Floridian and Cactus Politics, specializing in national and state-level politics. With three years' experience covering federal Florida, and Arizona politics, they have been cited by NewsBreak, SGT Report, Lucianne.com, and Cause Action. Email: grayson@dnm.news

Recent Posts

Alma Hernandez Condemns Rocque Perez's Controversial Social Media Comments

State Representative Alma Hernandez (D-20) condemned previous remarks made by her Democratic primary opponent for…

16 hours ago

Mark Kelly Demands Transparency on Cost of Iran War

Senator Mark Kelly (D-AZ) is spearheading a request to the Congressional Budget Office (CBO) to…

18 hours ago

Yassamin Ansari Continues to Fight For Epstein Survivors after Pam Bondi’s Testimony

Representative Yassamin Ansari (D-AZ) accused the Justice Department and Republican congressional leadership today of orchestrating…

19 hours ago

Eli Crane Cheers Federal Cotton Plan Aimed at Struggling Farmers

The federal government is making a big bet on American cotton, and Representative Eli Crane…

21 hours ago

Stephanie Simacek Demands Censure After School Board Member Gives Nazi Salute at Public Meeting

A Deer Valley Unified School District board member is facing mounting calls for accountability after…

22 hours ago

Ruben Gallego Spearheads Letter Against Another Proposed HUD Reform on Rental Assistance

Senator Ruben Gallego (D-AZ) is leading his fellow Senate Banking, Housing, and Urban Affairs Committee…

22 hours ago